Treatment of chancroid with erythromycin. A clinical and microbiological appraisal
- PMID: 6603249
- PMCID: PMC1046197
- DOI: 10.1136/sti.59.4.265
Treatment of chancroid with erythromycin. A clinical and microbiological appraisal
Abstract
One hundred and thirty seven patients presenting with genital ulcerations from which Haemophilus ducreyi was isolated were treated with erythromycin stearate 500 mg every six hours for seven days. Of these, 91 (66%) had associated inguinal lymphadenopathy. Only two of the 100 patients who returned after one week showed no clinical improvement. Despite decrease in size H ducreyi was reisolated from the ulcers of three patients, two of whom had not complied with treatment. The patients were treated for a further week either with erythromycin or with a placebo preparation and on day 14 no discernible difference in clinical response was evident. H ducreyi was not reisolated from any lesion. In contrast, the natural course of development of associated lymphadenopathy was not modified by treatment. H ducreyi was not, however, isolated from any gland after the start of treatment. Side effects attributable to erythromycin were minimal and treatment had to be discontinued in only two patients. This study clearly indicates that treatment with erythromycin for one week results in rapid healing of lesions and the elimination of H ducreyi from both ulcers and associated lymph glands.
Similar articles
-
Antimicrobial therapy of chancroid: effectiveness of erythromycin.J Infect Dis. 1983 Oct;148(4):726-31. doi: 10.1093/infdis/148.4.726. J Infect Dis. 1983. PMID: 6355314 Clinical Trial.
-
A comparative study of spectinomycin and erythromycin in the treatment of chancroid.J Antimicrob Chemother. 1990 Sep;26(3):429-34. doi: 10.1093/jac/26.3.429. J Antimicrob Chemother. 1990. PMID: 2146242 Clinical Trial.
-
A prospective clinical and bacteriologic study of inguinal buboes in Thai men.Clin Infect Dis. 1996 Feb;22(2):233-9. doi: 10.1093/clinids/22.2.233. Clin Infect Dis. 1996. PMID: 8838178
-
Chancroid and granuloma inguinale.Clin Lab Med. 1989 Sep;9(3):535-43. Clin Lab Med. 1989. PMID: 2676322 Review.
-
Advances in the diagnosis and management of chancroid.Sex Transm Dis. 1986 Jul-Sep;13(3 Suppl):189-91. doi: 10.1097/00007435-198607000-00019. Sex Transm Dis. 1986. PMID: 3532370 Review.
Cited by
-
Treatment of chancroid.Antimicrob Agents Chemother. 1990 Jul;34(7):1308-11. doi: 10.1128/AAC.34.7.1308. Antimicrob Agents Chemother. 1990. PMID: 2201249 Free PMC article. Review. No abstract available.
-
Antimicrobial susceptibility and characterization of outer membrane proteins of Haemophilus ducreyi isolated in Thailand.J Clin Microbiol. 1985 Mar;21(3):442-4. doi: 10.1128/jcm.21.3.442-444.1985. J Clin Microbiol. 1985. PMID: 3872313 Free PMC article.
-
Treating chancroid: summary of studies in southern Africa.Genitourin Med. 1989 Jan;65(1):54-7. doi: 10.1136/sti.65.1.54. Genitourin Med. 1989. PMID: 2629710 Free PMC article.
-
Evaluation of 500- and 1,000-mg doses of ciprofloxacin for the treatment of chancroid.Antimicrob Agents Chemother. 1988 May;32(5):723-5. doi: 10.1128/AAC.32.5.723. Antimicrob Agents Chemother. 1988. PMID: 3293526 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources